AVANZANITE Trademark

Trademark Overview


On Monday, August 2, 2021, a trademark application was filed for AVANZANITE with the United States Patent and Trademark Office. The USPTO has given the AVANZANITE trademark a serial number of 79321187. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. The AVANZANITE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; medical and veterinary pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic,...
avanzanite

General Information


Serial Number79321187
Word MarkAVANZANITE
Filing DateMonday, August 2, 2021
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7014563
Registration DateTuesday, April 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; medical and veterinary pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biotechnological preparations for medical, pharmaceutical and veterinary purposes, namely, biotechnological preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biological implants, namely, a vital processed human or animal connective tissue; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; chemico pharmaceutical preparations, namely, preparations for pharmaceutical or medical purposes for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic foods and substances adapted for medical or veterinary use, namely, dietetic preparations adapted for medical purposes, dietetic foods adapted for medical use, dietetic sugar substitutes for medical use; dietary supplements for human beings and animals; medical plasters, materials for dressings, namely, sterilized dressing, bandages for dressings, wadding for dressings; disinfectants; preparations for destroying vermin

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressNL

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNL

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNL

Trademark Events


Event DateEvent Description
Monday, August 14, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 21, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 21, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Monday, March 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 1, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, January 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 12, 2022EXAMINER'S AMENDMENT ENTERED
Monday, December 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 12, 2022EXAMINERS AMENDMENT E-MAILED
Monday, December 12, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 5, 2022REFUSAL PROCESSED BY IB
Friday, June 10, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 9, 2022REFUSAL PROCESSED BY MPU
Saturday, May 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 6, 2022NON-FINAL ACTION WRITTEN
Friday, April 29, 2022ASSIGNED TO EXAMINER
Tuesday, October 5, 2021APPLICATION FILING RECEIPT MAILED
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 30, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB